LAS VEGAS, NV / ACCESSWIRE / April 28, 2016 / Neutra Corp. (OTCQB: NTRR) and other companies supplying products and services to the fast-growing U.S. cannabis industry received good news this week when Marijuana Business Daily reported strong support for legalization in states that could vote on the issue this November.
Support for recreational cannabis legalization remains particularly strong in California, where 60 percent of voters support adult-use legalization, Voters there support legalization by a solid 60%, according to a recent Probolsky Research poll.
Odds of a legalization victory also appear good in Massachusetts and Michigan, where efforts are underway to get cannabis initiatives onto the fall ballot. About 53% of voters in each state support rec legalization, according to more recent polls.
Nevada and Arizona could consider legalization initiatives this year, too, with more states likely to follow in the coming years. As more cannabis markets open up nationwide, demand is expected to rise significantly. Such rapid growth has led to significant challenges for the industry, including supplying a huge amount of cannabis crops without the use of potentially hazardous pesticides and making cannabis treatments safer, more discrete and more reliable for patients.
NTRR is hard at work marketing and promoting new, antimicrobial alternatives to harsh chemicals used in cannabis farms. In 2016, NTRR plans to continue to source out solutions for cannabis producers and consumers alike as the regulated cannabis industry continues to swell in the United States, Canada and beyond. For more information on the company's mission, please visit http://neutrainc.com/investors.
About Neutra Corp.
As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how they grow, what they grow, and how they consume cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, NTRR is constantly combing the industry for the latest and greatest to test, prove and bring to market.
By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (NASDAQ: GWPH), Cara Therapeutics Inc. (NASDAQ: CARA) and 22nd Century Group, Inc. (NASDAQ: XXII). For investing information and performance data, please visit www.neutrainc.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
[email protected]
SOURCE: Neutra Corp.